Follow-up results of looking at treatment with ibrutinib on CLL patient survival and adverse events
The future of predicting outcomes for patients with MPNs: a patient knowledge bank
How can MRD and disease be assessed in routine practice?
The management of transaminitis in patients receiving idelalisib
Impressive results from phase 3 RESONATE trial in CLL